# Office of the Director

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/office-of-the-director/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 86.4 |
| Citations | 926,833 |
| City | Bethesda |
| Country | US |
| Description | Office of the Director is a research organisation in Bethesda, US. OpenAlex records 5,986 works and 926,833 citations for it. 1,077 researchers list it as their most recent affiliation. |
| Homepage | http://www.nih.gov/icd/od/ |
| OpenAlex ID | https://openalex.org/I4210091794 |
| Researchers | 1,077 |
| ROR ID | https://ror.org/00fj8a872 |
| Type | other |
| Works | 5,986 |

## University papers

Showing 12 of 27.

- [Topoisomerase I inhibitors: camptothecins and beyond](https://scholariq.org/papers/topoisomerase-i-inhibitors-camptothecins-and-beyond/)
- [Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors](https://scholariq.org/papers/trapping-of-parp1-and-parp2-by-clinical-parp-inhibitors/)
- [DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs](https://scholariq.org/papers/dna-topoisomerases-and-their-poisoning-by-anticancer-and-antibacterial-drugs/)
- [γH2AX and cancer](https://scholariq.org/papers/h2ax-and-cancer/)
- [A gene expression database for the molecular pharmacology of cancer](https://scholariq.org/papers/a-gene-expression-database-for-the-molecular-pharmacology-of-cancer/)
- [Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group](https://scholariq.org/papers/eligibility-and-response-guidelines-for-phase-ii-clinical-trials-in-androgen/)
- [Roles of eukaryotic topoisomerases in transcription, replication and genomic stability](https://scholariq.org/papers/roles-of-eukaryotic-topoisomerases-in-transcription-replication-and-genomic/)
- [CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set](https://scholariq.org/papers/cellminer-a-web-based-suite-of-genomic-and-pharmacologic-tools-to-explore/)
- [Attention Bias Modification Treatment: A Meta-Analysis Toward the Establishment of Novel Treatment for Anxiety](https://scholariq.org/papers/attention-bias-modification-treatment-a-meta-analysis-toward-the-establishment/)
- [Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program](https://scholariq.org/papers/comprehensive-versus-usual-community-care-for-first-episode-psychosis-2-year/)
- [Drugging Topoisomerases: Lessons and Challenges](https://scholariq.org/papers/drugging-topoisomerases-lessons-and-challenges/)
- [Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action](https://scholariq.org/papers/laying-a-trap-to-kill-cancer-cells-parp-inhibitors-and-their-mechanisms-of/)

## University researchers

- [Yves Pommier](https://scholariq.org/researchers/yves-pommier/)

## University top topics

Showing 8 of 25.

- [Health and Medical Research Impacts](https://scholariq.org/topics/health-and-medical-research-impacts/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Ethics in Clinical Research](https://scholariq.org/topics/ethics-in-clinical-research/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.